These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 23506246)
41. Novel thermosensitive in situ gel based on poloxamer for uterus delivery. Lu C; Liu M; Fu H; Zhang W; Peng G; Zhang Y; Cao H; Luo L Eur J Pharm Sci; 2015 Sep; 77():24-8. PubMed ID: 25981887 [TBL] [Abstract][Full Text] [Related]
42. [Thermosensitive in situ gel of boanmycin hydrochloride for injection]. Ding WM; Li M; Li GL; Xu HZ; Chen RX Yao Xue Xue Bao; 2011 Jun; 46(6):727-32. PubMed ID: 21882536 [TBL] [Abstract][Full Text] [Related]
43. Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: design and in vitro evaluation. Radivojša M; Grabnar I; Ahlin Grabnar P Eur J Pharm Sci; 2013 Sep; 50(1):93-101. PubMed ID: 23524253 [TBL] [Abstract][Full Text] [Related]
44. Parenteral iron nutrition: Iron dextran-poloxamer thermosensitive hydrogel for prolonged intramuscular iron supplementation. Durán E; Sepúlveda M; Romero-Hasler P; Valdés F; Villamizar Sarmiento MG; Soto-Bustamante E; Neira-Carrillo A; Neira V; Ignacio Covarrubias J; Oyarzun-Ampuero F; Burgess DJ; Valenzuela C Int J Pharm; 2024 Sep; 663():124559. PubMed ID: 39122197 [TBL] [Abstract][Full Text] [Related]
45. [Optimization of ligustrazine phosphate thermosensitive gel formulation by central composite design-response surface methodology]. Meng DM; Xu YH; Ding PT; Deng YJ; Wei MY Zhong Yao Cai; 2008 Feb; 31(2):286-8. PubMed ID: 18619280 [TBL] [Abstract][Full Text] [Related]
46. Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide. Yuan Y; Cui Y; Zhang L; Zhu HP; Guo YS; Zhong B; Hu X; Zhang L; Wang XH; Chen L Int J Pharm; 2012 Jul; 430(1-2):114-9. PubMed ID: 22503953 [TBL] [Abstract][Full Text] [Related]
47. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier. Hyun H; Kim YH; Song IB; Lee JW; Kim MS; Khang G; Park K; Lee HB Biomacromolecules; 2007 Apr; 8(4):1093-100. PubMed ID: 17326678 [TBL] [Abstract][Full Text] [Related]
48. Improved delivery of angiogenesis inhibitors from PLGA:poloxamer blend micro- and nanoparticles. d'Angelo I; Parajó Y; Horváth A; Kéri G; La Rotonda MI; Alonso MJ J Microencapsul; 2010; 27(1):57-66. PubMed ID: 19545221 [TBL] [Abstract][Full Text] [Related]
49. In situ thermo-co-electroresponsive mucogel for controlled release of bioactive agent. Akilo OD; Kumar P; Choonara YE; du Toit LC; Pradeep P; Modi G; Pillay V Int J Pharm; 2019 Mar; 559():255-270. PubMed ID: 30690131 [TBL] [Abstract][Full Text] [Related]
50. Synthesis and characterization of Poloxamer 188-grafted heparin copolymer. Tian JL; Zhao YZ; Jin Z; Lu CT; Tang QQ; Xiang Q; Sun CZ; Zhang L; Xu YY; Gao HS; Zhou ZC; Li XK; Zhang Y Drug Dev Ind Pharm; 2010 Jul; 36(7):832-8. PubMed ID: 20515404 [TBL] [Abstract][Full Text] [Related]
51. Pluronic lecithin organogel as a topical drug delivery system. Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074 [TBL] [Abstract][Full Text] [Related]
52. Sustained-release of urease from a poloxamer gel matrix. Fults KA; Johnston TP J Parenter Sci Technol; 1990; 44(2):58-65. PubMed ID: 2338605 [TBL] [Abstract][Full Text] [Related]
53. In vitro release of lysozyme from gelatin microspheres: effect of cross-linking agents and thermoreversible gel as suspending medium. Hiwale P; Lampis S; Conti G; Caddeo C; Murgia S; Fadda AM; Monduzzi M Biomacromolecules; 2011 Sep; 12(9):3186-93. PubMed ID: 21809827 [TBL] [Abstract][Full Text] [Related]
54. Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation. Fouad SA; Basalious EB; El-Nabarawi MA; Tayel SA Int J Pharm; 2013 Sep; 453(2):569-78. PubMed ID: 23792042 [TBL] [Abstract][Full Text] [Related]
55. [Diffusion behaviors of drugs in thermosensitive in situ gels]. Wei G; Lu WY; Zheng JM Yao Xue Xue Bao; 2004 Mar; 39(3):232-5. PubMed ID: 15171663 [TBL] [Abstract][Full Text] [Related]
56. Interleukin-1 receptor antagonist improves normoglycemia and insulin sensitivity in diabetic Goto-Kakizaki-rats. Akash MS; Rehman K; Sun H; Chen S Eur J Pharmacol; 2013 Feb; 701(1-3):87-95. PubMed ID: 23348707 [TBL] [Abstract][Full Text] [Related]
57. Poloxamer 407/188 Binary Thermosensitive Gel as a Moxidectin Delivery System: In Vitro Release and In Vivo Evaluation. Ruan X; Hu J; Lu L; Wang Y; Tang C; Liu F; Gao X; Zhang L; Wu H; Huang X; Wei Q Molecules; 2022 May; 27(10):. PubMed ID: 35630537 [TBL] [Abstract][Full Text] [Related]
58. Development and characterization of thermosensitive pluronic-based metronidazole in situ gelling formulations for vaginal application. Ibrahim el-SA; Ismail S; Fetih G; Shaaban O; Hassanein K; Abdellah NH Acta Pharm; 2012 Mar; 62(1):59-70. PubMed ID: 22472449 [TBL] [Abstract][Full Text] [Related]
59. Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation. Cafaggi S; Russo E; Caviglioli G; Parodi B; Stefani R; Sillo G; Leardi R; Bignardi G Eur J Pharm Sci; 2008 Sep; 35(1-2):19-29. PubMed ID: 18598763 [TBL] [Abstract][Full Text] [Related]
60. [Preparation and release in vitro of injectable thermosensitive in situ gel of Glabrous Sarcandra herb extract]. Chen Y; Li L; Liu H; Peng B; Jin R Zhongguo Zhong Yao Za Zhi; 2009 Oct; 34(20):2586-9. PubMed ID: 20069897 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]